Delivery Order SPE2DB20D3303-SPE2DB25FA3QB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Desonide 0.05% Cream (60 grams) with a ceiling value of $1,000.93 under a firm fixed-price contract awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. This delivery order is not set-aside and represents a competitive award to the major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The product will be performed at...
- This delivery order, issued September 9, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Desonide 0.05% Cream in 60-gram units with a ceiling value of $1,235.34. The order is firm fixed price with no set-aside designation, indicating competitive award. Performance is based in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This award represents a child contract under AmerisourceBergen's larger DLA Troop...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventeen thousand four hundred dollars to Amerisourcebergen Drug Corporation for DESONIDE 0.05% cream. Under this single award, the prime contractor will deliver sixty grams of the topical corticosteroid to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania, with performance required between September 26-27, 2023. As the Defense Logistics Agency manages the global supply chain for the...
- The Defense Logistics Agency Troop Support Medical awarded a $52,140 delivery order to Amerisourcebergen Drug Corporation for 60 grams of Desonide 0.05% cream. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania, with performance spanning August 25-28, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this delivery order for a topical corticosteroid cream supports the Agency's mission to...
- The Defense Logistics Agency awarded a $21,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Desonide 0.05% cream in 15 gram containers. To be performed in Conshohocken, Pennsylvania from July 28 through July 31, 2023, this order is in support of the DLA's medical supply procurement programs. As a leading pharmaceutical distributor, Amerisourcebergen will deliver the prescribed dermatological cream from its corporate headquarters and distribution facility without...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Desonide 0.05% Lotion, a pharmaceutical product, with a ceiling value of $2,453.30 and a period of performance through August 27, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by...
- The Defense Logistics Agency awarded a $10,000 delivery order to Amerisourcebergen Drug Corporation for Desonide 0.05% ointment. The firm fixed price order is for 15 grams of the ointment and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 6, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services. This small order for a topical corticosteroid medication is...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at forty-three thousand two hundred dollars to Amerisourcebergen Drug Corporation for DESONIDE 0.05% cream in 15gm containers. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by July 24, 2023 under the terms of this order. The Defense Logistics Agency routinely issues delivery orders against various...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,213.24 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide a 15-gram tube of Desonide 0.05% cream. This order was placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- The Defense Logistics Agency awarded a $138,360 delivery order to Amerisourcebergen Drug Corporation for Desonide 0.05% cream. The firm fixed price order is to supply 60 grams of the topical corticosteroid cream to a location in Conshohocken, Pennsylvania by September 1, 2023. Amerisourcebergen will perform under the contract as the prime contractor. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to provide medical supplies and...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3QBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,598.23 to AmerisourceBergen Drug Corp for the supply of Desonide 0.05% Lotion (118ml), a topical corticosteroid medication. This firm fixed-price delivery order, awarded on September 12, 2025, represents a non-set-aside competitive award with an ultimate completion date of September 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's role as a major pharmaceutical distributor positions it as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability to fulfill diverse medical supply requirements through open competition, ranging from small-value transactions to substantial orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/12/25 |